Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Minority Interest (2022 - 2023)

Zentalis Pharmaceuticals (ZNTL) has 2 years of Minority Interest data on record, last reported at $107000.0 in Q4 2023.

  • For Q4 2023, Minority Interest fell 51.58% year-over-year to $107000.0; the TTM value through Dec 2023 reached $107000.0, down 51.58%, while the annual FY2023 figure was $107000.0, 51.58% down from the prior year.
  • Minority Interest reached $107000.0 in Q4 2023 per ZNTL's latest filing, down from $221000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at $234000.0 in Q3 2022 and bottomed at $107000.0 in Q4 2023.